Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 538732, 7 pages
http://dx.doi.org/10.1155/2015/538732
Research Article

Influence of Cardiorespiratory Fitness on PPARG mRNA Expression Using Monozygotic Twin Case Control

1Departamento de Educação Física da Universidade Estadual do Centro-Oeste (UNICENTRO), Rua Simeão Camargo Varela de Sá, 03, 85040-080 Guarapuava, PR, Brazil
2Departamento de Educação Física da Universidade Estadual Paulista (UNESP), Avenida 24 A 1515, 13506-900 Rio Claro, SP, Brazil
3Departamento de Análises Clínicas e Toxicológicas da Universidade Federal do Rio Grande do Norte (UFRN), Rua General Gustavo Cordeiro de Farias, 384, 59012-570 Natal, RN, Brazil
4Departamento de Análises Clínicas e Toxicológicas da Universidade de São Paulo (USP), Avenida Professor Lineu Prestes, 580, 05508-000 São Paulo, SP, Brazil

Received 22 October 2014; Revised 22 February 2015; Accepted 1 March 2015

Academic Editor: Norman Cameron

Copyright © 2015 Marcos Roberto Queiroga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Berger and D. E. Moller, “The mechanisms of action of PPARs,” Annual Review of Medicine, vol. 53, pp. 409–435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Desvergne, L. Michalik, and W. Wahli, “Be fit or be sick: peroxisome proliferator-activated receptors are down the road,” Molecular Endocrinology, vol. 18, no. 6, pp. 1321–1332, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Auwerx, “PPARgamma, the ultimate thrifty gene,” Diabetologia, vol. 42, no. 9, pp. 1033–1049, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Uruno, K. Matsuda, N. Noguchi et al., “Peroxisome proliferator-activated receptor-γ suppresses CYP11B2 expression and aldosterone production,” Journal of Molecular Endocrinology, vol. 46, no. 1, pp. 37–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sugawara, A. Uruno, M. Kudo, K. Matsuda, C. W. Yang, and S. Ito, “PPARγ agonist beyond glucose lowering effect,” The Korean Journal of Internal Medicine, vol. 26, no. 1, pp. 19–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Barroso, M. Gurnell, V. E. F. Crowley et al., “Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension,” Nature, vol. 402, no. 6764, pp. 880–883, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Jiang, A. T. Ting, and B. Seed, “PPAR-γ agonists inhibit production of monocyte inflammatory cytokines,” Nature, vol. 391, no. 6662, pp. 82–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. F. M. A. C. Martens, F. L. J. Visseren, E. J. P. de Koning, and T. J. Rabelink, “Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes,” Journal of Cardiovascular Pharmacology, vol. 46, no. 6, pp. 773–778, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Staniloae, V. Mandadi, D. Kurian et al., “Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease,” Cardiology, vol. 108, no. 3, pp. 164–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. H. Chung, S. W. Lim, K. O. Ahn et al., “Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases,” Nephrology, vol. 10, supplement 2, pp. S40–S43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Blanquicett, J. Roman, and C. M. Hart, “Thiazolidinediones as anticancer agents,” Cancer Therapy, vol. 6, pp. 25–34, 2008. View at Google Scholar
  12. N. Stefan, C. Thamer, H. Staiger et al., “Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 5, pp. 1827–1833, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. St-Pierre, J. Lin, S. Krauss et al., “Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells,” The Journal of Biological Chemistry, vol. 278, no. 29, pp. 26597–26603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Lucia, F. Gómez-Gallego, I. Barroso et al., “PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men,” Journal of Applied Physiology, vol. 99, no. 1, pp. 344–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Nyholm, A. Mengel, S. Nielsen et al., “Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism,” Diabetologia, vol. 39, no. 7, pp. 813–822, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Wei, L. W. Gibbons, T. L. Mitchell, J. B. Kampert, C. D. Lee, and S. N. Blair, “The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men,” Annals of Internal Medicine, vol. 130, no. 2, pp. 89–96, 1999. View at Google Scholar
  17. E. E. Spangenburg, D. A. Brown, M. S. Johnson, and R. L. Moore, “Alterations in peroxisome proliferator-activated receptor mRNA expression in skeletal muscle after acute and repeated bouts of exercise,” Molecular and Cellular Biochemistry, vol. 332, no. 1-2, pp. 225–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. W. Thomas, N. A. Davies, H. Moir et al., “Exercise-associated generation of PPARγ ligands activates PPARγ signaling events and upregulates genes related to lipid metabolism,” Journal of Applied Physiology, vol. 112, no. 5, pp. 806–815, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. F. W. Booth, M. V. Chakravarthy, and E. E. Spangenburg, “Exercise and gene expression: physiological regulation of the human genome through physical activity,” The Journal of Physiology, vol. 543, no. 2, pp. 399–411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Samaras, P. J. Kelly, M. N. Chiano, T. D. Spector, and L. V. Campbell, “Genetic and environmental influences on total-body and central abdominal fat: the effect of physical activity in female twins,” Annals of Internal Medicine, vol. 130, no. 11, pp. 873–882, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Mustelin, K. H. Pietiläinen, A. Rissanen et al., “Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 295, no. 1, pp. E148–E154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Boomsma, A. Busjahn, and L. Peltonen, “Classical twin studies and beyond,” Nature Reviews Genetics, vol. 3, no. 11, pp. 872–882, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Queiroga, R. A. Barbieri, S. A. Ferreira et al., “Glucose metabolism in discordant monozygotic twins for cardiorespiratory fitness,” Revista Paulista de Pediatria, vol. 31, no. 1, pp. 77–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. F. B. Hu, J. Goldberg, D. Hedeker, and W. G. Henderson, “Modelling ordinal responses from co-twin control studies,” Statistics in Medicine, vol. 17, no. 9, pp. 957–970, 1998. View at Publisher · View at Google Scholar
  25. T. Lohman, A. Roche, and R. Martorell, Eds., Anthropometric Standardization Reference Manual, Human Kinetics, Champaign, Ill, USA, 1988.
  26. P. Setty, B. V. Padmanabha, and B. R. Doddamani, “Correlation between obesity and cardio respiratory fitness,” International Journal of Medical Science and Public Health, vol. 2, no. 3, pp. 300–304, 2013. View at Publisher · View at Google Scholar
  27. A. J. Vidal-Puig, R. V. Considine, M. Jimenez-Liñan et al., “Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids,” The Journal of Clinical Investigation, vol. 99, no. 10, pp. 2416–2422, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. L. R. Butcher, A. Thomas, K. Backx, A. Roberts, R. Webb, and K. Morris, “Low-intensity exercise exerts beneficial effects on plasma lipids via PPARgamma,” Medicine and Science in Sports and Exercise, vol. 40, no. 7, pp. 1263–1270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Qi, F. B. Hu, and G. Hu, “Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes,” Current Molecular Medicine, vol. 8, no. 6, pp. 519–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Aires, M. Pratt, F. Lobelo, R. M. Santos, M. P. Santos, and J. Mota, “Associations of cardiorespiratory fitness in children and adolescents with physical activity, active commuting to school, and screen time,” Journal of Physical Activity and Health, vol. 8, pp. S198–205, 2011. View at Google Scholar · View at Scopus
  31. P.-L. Hsieh, M.-L. Chen, C.-M. Huang, W.-C. Chen, C.-H. Li, and L.-C. Chang, “Physical activity, body mass index, and cardiorespiratory fitness among school children in Taiwan: a cross-sectional study,” International Journal of Environmental Research and Public Health, vol. 11, no. 7, pp. 7275–7285, 2014. View at Publisher · View at Google Scholar
  32. H. H. M. Maes, G. P. Beunen, R. F. Vlietinck et al., “Inheritance of physical fitness in 10-yr-old twins and their parents,” Medicine & Science in Sports & Exercise, vol. 28, no. 12, pp. 1479–1491, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Bouchard, P. An, T. Rice et al., “Familial aggregation of VO(2max) response to exercise training: results from the HERITAGE family study,” Journal of Applied Physiology, vol. 87, no. 3, pp. 1003–1008, 1999. View at Google Scholar · View at Scopus
  34. A. Vaag, J. E. Henriksen, S. Madsbad, N. Holm, and H. Beck-Nielsen, “Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus,” The Journal of Clinical Investigation, vol. 95, no. 2, pp. 690–698, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-W. Guo, “Does higher concordance in monozygotic twins than in dizygotic twins suggest a genetic component?” Human Heredity, vol. 51, no. 3, pp. 121–132, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. C. H. Hawkes, “Twin studies in medicine—what do they tell us?” QJM: Monthly Journal of the Association of Physicians, vol. 90, no. 5, pp. 311–321, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. T. W. Rowland, Pediatric Laboratory Exercise Testing: Clinical Guidelines, Human Kinetics, Champaign, Ill, USA, 1993.
  38. T. Leskinen, K. Waller, S. Mutikainen et al., “Effects of 32-year leisure time physical activity discordance in twin pairs on health (TWINACTIVE study): aims, design and results for physical fitness,” Twin Research and Human Genetics, vol. 12, no. 1, pp. 108–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. C. Hannukainen, P. Nuutila, B. Ronald et al., “Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins,” The Journal of Physiology, vol. 578, no. 1, pp. 347–358, 2007. View at Publisher · View at Google Scholar · View at Scopus